يعرض 1 - 13 نتائج من 13 نتيجة بحث عن '"arginase 1 deficiency"', وقت الاستعلام: 0.46s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المساهمون: National Institutes of Health Bethesda, MD, USA (NIH), St Jude Children's Research Hospital, Purdue University West Lafayette, National Institute of Environmental Health Sciences Durham, NC, USA (NIEHS-NIH), King‘s College London, National Heart, Lung, and Blood Institute Bethesda (NHLBI), Duke University Durham, Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), National Cancer Institute Bethesda (NCI-NIH), National Institute of Allergy and Infectious Diseases Phnom Penh, Cambodia (NIAID), National Institute of Allergy and Infectious Diseases Bethesda (NIAID-NIH), National Institutes of Health Bethesda, MD, USA (NIH)-National Institutes of Health Bethesda, MD, USA (NIH), Laboratory of Biological Modeling (NIDDK), Leopold Franzens Universität Innsbruck - University of Innsbruck, University Children's Hospital Basel, Switzerland

    المصدر: ISSN: 1074-7613 ; Immunity ; https://hal.science/hal-04600452 ; Immunity, 2023, 56 (9), pp.2036-2053.e12. ⟨10.1016/j.immuni.2023.07.014⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37572656; PUBMED: 37572656; PUBMEDCENTRAL: PMC10576612

  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
  9. 9
    Academic Journal

    وصف الملف: application/pdf

    Relation: Diaz, George A.; Schulze, Andreas; McNutt, Markey C.; Leão‐teles, Elisa; Merritt, J. Lawrence; Enns, Gregory M.; Batzios, Spyros; Bannick, Allison; Zori, Roberto T.; Sloan, Leslie S.; Potts, Susan L.; Bubb, Gillian; Quinn, Anthony G. (2021). "Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency." Journal of Inherited Metabolic Disease 44(4): 847-856.; https://hdl.handle.net/2027.42/168523; Journal of Inherited Metabolic Disease; Sin YY, Baron G, Schulze A, Funk CD. Arginase- 1 deficiency. J Mol Med. 2015; 93 ( 12 ): 1287 - 1296.; Cederbaum SD, Shaw KN, Spector EB, Verity MA, Snodgrass PJ, Sugarman GI. Hyperargininemia with arginase deficiency. Pediatr Res. 1979; 13: 827 - 833.; Waisbren SE, Cuthbertson D, Burgard P, Holbert A, McCarter R, Cederbaum S. Members of the urea cycle disorders consortium. Biochemical markers and neuropsychological functioning in distal urea cycle disorders. J Inherit Metab Dis. 2018; 41 ( 4 ): 657 - 667.; Carvalho DR, Brand GD, Brum JM, Takata RI, Speck- Martins CE, Pratesi R. Analysis of novel ARG1 mutations causing hyperargininemia and correlation with arginase I activity in erythrocytes. Gene. 2012; 509 ( 1 ): 124 - 130.; Scholl- Bürgi S, Baumgartner Sigl S, Häberle J, et al. Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency. J Inherit Metab Dis. 2008; 31 ( S2 ): S323 - S328.; De Deyn P, Marescau B, Qureshi I, Mori A. Hyperargininemia: a treatable inborn error of metabolism? The Fourth International Symposium on Guanidino Compounds in Biology and Medicine: Guanidino Compounds in Biology & Medicine II; 1997: 53 - 69.; Schlune A, vom Dahl S, Häussinger D, Ensenauer R, Mayatepek E. Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. Amino Acids. 2015; 47: 1751 - 1762.; Geiger R, Strasak A, Treml B, et al. Six- minute walk test in children and adolescents. J Pediatr. 2007; 150 ( 4 ): 395 - 399.; Deshmukh DR, Sarnaik AP, Marescau B, et al. Guanidino compound metabolism in arginine- free diet induced hyperammonemia. Enzyme. 1991; 45 ( 3 ): 128 - 136.; Sakiyama T, Nakabayashi H, Shimizu H, Kondo W, Kodama S, Kitagawa T. A successful trial of enzyme replacement therapy in a case of argininemia. Tohoku J Exp Med. 1984; 142 ( 3 ): 239 - 248.; Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998; 336 ( Pt 1 ): 1 - 17.; Oeffinger D, Bagley A, Rogers S, et al. Outcome tools used for ambulatory children with cerebral palsy: responsiveness and minimum clinically important differences. Dev Med Child Neurol. 2008; 50 ( 12 ): 918 - 925.; Schrover R, Evans K, Giugliani R, Noble I, Bhattacharya K. Minimal clinically important difference for the 6- min walk test: literature review and application to Morquio a syndrome. Orphanet J Rare Dis. 2017; 12 ( 1 ): 78.; NIH. ToolboxR Scoring and Interpretation Guide for the iPad; 2016.; Haller C, Song W, Cimms T, et al. Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study population. JIMD Rep. 2019; 49 ( 1 ): 53 - 62.; Burrage LC, Sun Q, Elsea SH, et al. Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency. Hum Mol Genet. 2015; 24 ( 22 ): 6417 - 6427.; Desnick RJ, Schuchman EH. Enzyme replacement therapy for lysosomal diseases: lessons from 20- years of experience and remaining challenges. Annu Rev Genomics Hum Genet. 2012; 13: 307 - 335.; Lambert MA, Marescau B, Desjardins M, et al. Hyperargininemia: intellectual and motor improvement related to changes in biochemical data. J Pediatr. 1991; 118 ( 3 ): 421 - 424.; Cederbaum SD, Moedjono SJ, Shaw KN, Carter M, Naylor E, Walzer M. Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet. J Inherit Metab Dis. 1982; 5: 95 - 99.; Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019; 42 ( 6 ): 1192 - 1230.; Huemer M, Carvalho DR, Brum JM, et al. Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency. J Inherit Metab Dis. 2016; 39 ( 3 ): 331 - 340.

  10. 10
  11. 11
  12. 12
    Dissertation/ Thesis

    المؤلفون: Baron, Garrett

    المساهمون: Funk, Colin D., Biomedical and Molecular Sciences

    Relation: Canadian theses; http://hdl.handle.net/1974/14981

  13. 13
    Electronic Resource